These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6460826)

  • 1. Specific immunoregulation abnormality in insulin-dependent diabetes mellitus.
    Fairchild RS; Kyner JL; Abdou NI
    J Lab Clin Med; 1982 Feb; 99(2):175-86. PubMed ID: 6460826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective suppressor cell generation in juvenile onset diabetes.
    Lederman MM; Ellner JJ; Rodman HM
    J Immunol; 1981 Nov; 127(5):2051-5. PubMed ID: 6457859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of suppressor T cell function and circulating immune complexes in chronic active liver diseases.
    Hotta R; Kuriki J; Kakumu S
    Clin Exp Immunol; 1981 Nov; 46(2):375-81. PubMed ID: 6461458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in old people and in diabetics: correlation with autoantibodies.
    Delespesse G; Gausset P; Sarfati M; Dubi-Rucquoy M; Debisschop MJ; van Haelst L
    Clin Exp Immunol; 1980 Apr; 40(1):96-102. PubMed ID: 6993080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thymosin and insulin on suppressor T cell in type 1 diabetes.
    Wang SH; Chen G; Zhang K
    Diabetes Res; 1992 Jan; 19(1):21-9. PubMed ID: 1468183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological suppressor cell activity in insulin dependent diabetes.
    Slater LM; Murray SL; Kershnar A; Mosier MA
    J Clin Lab Immunol; 1980 Mar; 3(2):105-9. PubMed ID: 6451707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes and B lymphocytes in diabetic patients with and without microangiopathy.
    Barañao RI; Tesone PA; Garberi JC; Mendelson MJ; Rumi LS
    Acta Physiol Pharmacol Latinoam; 1985; 35(2):145-51. PubMed ID: 2938403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitus.
    Pozzilli P; Zuccarini O; Sensi M; Spencer KM; Bottazzo G
    Biomed Biochim Acta; 1984; 43(5):621-5. PubMed ID: 6236800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile.
    Schmidli RS; DeAizpurua HJ; Harrison LC; Colman PG
    J Autoimmun; 1994 Feb; 7(1):55-66. PubMed ID: 8198702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease.
    Yoshikawa N; Morita T; Arreaza G; Resetkova E; Mukuta T; Volpé R
    Clin Invest Med; 1995 Apr; 18(2):91-8. PubMed ID: 7788961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus.
    Buschard K; Madsbad S; Rygaard J
    Clin Exp Immunol; 1980 Jul; 41(1):25-32. PubMed ID: 6449332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of islet cell antibodies and its correlation with glucose and insulin response to oral glucose tolerance test in 1st degree relatives of insulin dependent diabetes mellitus probands.
    Merchant PC; Godse CS; Varthakavi PK; Patel KL; Nihalani KD
    J Assoc Physicians India; 1998 May; 46(5):417-23. PubMed ID: 11273280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The temporal association between gamma delta T cells and the natural history of insulin-dependent diabetes.
    Lang FP; Pollock BH; Riley WJ; Maclaren NK; Barrett DJ
    J Autoimmun; 1993 Feb; 6(1):107-19. PubMed ID: 8457282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to albumin in the plasma of patients with diabetes mellitus. Relationship with circulating immune complexes.
    Triolo G; Giardina E; Rinaldi A; Seddio G; Bompiani GD
    J Clin Lab Immunol; 1986 Nov; 21(3):113-5. PubMed ID: 3560190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
    Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
    Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Islet-cell antibodies and organ-specific antibodies in diabetic children and adolescents. Relationship with age, age at onset, duration of diabetes, residual insulin secretion and retinopathy (author's transl)].
    Dorchy H; Lemiere B; Toussaint D; Gausset P
    Nouv Presse Med; 1981 Sep; 10(34):2795-8. PubMed ID: 7031599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays.
    Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA
    J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.